Improved survival and local control after total mesorectal excision or D3 lymphadenectomy in the treatment of primary rectal cancer: An international analysis of 1411 patients

European Journal of Surgical Oncology

Volumn 25, Issue 4, 1999, Pages 368-374

  Havenga, K ^a   Enker, W E ^b   Norstein, J ^c   Moriya, Y ^d   Heald, R J ^e   Van Houwelingen, H C ^a   Van De Velde, C J H ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b BETH ISRAEL MEDICAL CENTER   (United States)

^c Riikshopitalet   (Norway)

^d National Cancer Center   (Japan)

^e NORTH HAMPSHIRE HOSPITAL   (United Kingdom)

Author keywords

Neoplasm recurrence, local; Rectal neoplasms; Survival rate

Indexed keywords

FLUOROURACIL; FOLINIC ACID;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; FEMALE; HUMAN; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECTUM CANCER; RECTUM TUMOR; RETROSPECTIVE STUDY;

EID: 0033180254     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1053/ejso.1999.0659     Document Type: Article

References (25)

1. Abulafi AM, Williams NS. Local recurrence of colorectal cancer: The problem, mechanisms, management and adjuvant therapy. Br J Surg 1994; 81: 7-19.
2. Quirke P, Durdey P, Dixon MF, Williams NS. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Lancet 1986; ii: 996-8.
3. Ng IO, Luk IS, Yuen ST, et al. Surgical lateral clearance in resected rectal carcinomas. Cancer 1993; 71: 1972-6.
4. Grotz RL, Pemberton JH, Gunderson LL. Treatment results with radical surgery. In: Cohen A, Winaver SJ, Friedman MA, Gundersson LL (eds) Cancer of the Colon, Rectum and Anus. New York: McGraw-Hill, 1995: 605-14.
5. Gastrointestinal Tumor Study Group. Prolongation of the disease-free interval in surgically treated rectal carcinoma. N Engl J Med 1985; 312: 1465-72.
6. Balslev I, Pedersen M, Teglbjaerg PS, et al. Postoperative radiotherapy in Dukes' B and C carcinoma of the rectum and rectosigmoid. Cancer 1986; 58: 22-8.
7. Krook JE, Moertel CG, Gunderson LL, et al. Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med 1991; 324: 709-15.
8. Swedish Rectal Cancer Trial. Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med 1997; 336: 980-7.
9. MacFarlane JK, Ryall RDH, Heald RJ. Mesorectal excision for rectal cancer. Lancet 1993; 341: 457-60.
10. Enker WE, Thaler HT, Cranor ML, Polyak T. Total mesorectal excision in the operative treatment of carcinoma of the rectum. J Am Coll Surg 1995; 181: 335-46.
11. Aitken RJ. Mesorectal excision for rectal cancer. Br J Surg 1996; 83: 214-6.
12. Moriya Y, Sugihara K, Akasu T, Fujita S. Importance of extended lymphadenectomy with lateral node dissection for advanced rectal cancer. World J Surg 1997; 21: 728-32.
13. Ibister WH. Basingstoke revisited. Aust N Z J Surg 1990; 60: 243-6.
14. Fielding LP. Mesorectal excision for rectal cancer. Lancet 1993; 341: 471-2.
15. American Joint Committee on Cancer. Manual for Staging of Cancer. 3rd Edn. Philadelphia: JB Lippincott, 1988.
16. Oncologie Vademecum. Leiden: Integraal Kankercentrum West, 1994.
17. Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-81.
18. Cox DR. Regression models and life-tables. J R Stat Soc (B) 1972; 34: 187-202.
19. McArdle CS, Hole D. Impact of variability among surgeons on postoperative morbidity and mortality und ultimate survival. Br Med J 1991; 302: 1501-5.
20. Wolff BG. Transabdominal surgery for rectal carcinoma: Low anterior resection and abdominal perineal resection. In: Donohue JH, van Heerden JA, Monson JR (eds) Atlas of Surgical Oncology. Cambridge, MA: Blackwell Science, 1995: 231-9.
21. Søreide O, Norstein J. Local recurrence after operative treatment of rectal carcinoma: A strategy for change. J Am Coll Surg 1997; 184: 84-92.
22. Feinstein AR, Sosin DM, Wells CK. The Will Rogers phenomenon: Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med 1985; 312: 1604-8.
23. Havenga K, Enker WE, McDermott K, Cohen AM, Minsky BD, Guillem J. Male and female sexual and urinary function after total mesorectal excision with autonomie nerve preservation for rectal cancer. J Am Coll Surg 1996; 182: 495-502.
24. Total mesorectal excision is optimal surgery for rectal cancer: A Scandinavian consensus. Editorial. Br J Surg 1995; 82: 1297-9.
25. Quirke P, Scott N. The pathologist's role in the assessment of local recurrence in rectal carcinoma. Surg Oncol Clin N Am 1992; 1: 1-17.